Across TCGA pan-cancer cohorts, SLC27A4 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated SLC27A4 data layer compared with 22 for mass-spec protein and 4 for mutation status.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher SLC27A4 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated SLC27A4 expression acts as an unfavorable survival marker, although some lineages such as HNSC and CCRCC show a favorable association.
HNSC, CCRCC, and LUAD are the cancer types where SLC27A4 mass-spec protein most reproducibly stratifies survival.